JACLYN ALDANA: Open Payments
NPI 1417465139 · TEMECULA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,007 in 205 payments from 22 companies in 2025. Trend: 2023 $4,262 · 2024 $3,050 · 2025 $4,007
Food & beverage: $3,978Education: $29
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $994 |
| UCB, Inc. | 29 | $664 |
| Amgen Inc. | 21 | $343 |
| GlaxoSmithKline, LLC. | 13 | $294 |
| Novartis Pharmaceuticals Corporation | 11 | $230 |
| Janssen Biotech, Inc. | 14 | $199 |
| Lilly USA, LLC | 9 | $195 |
| Mallinckrodt Hospital Products Inc. | 7 | $194 |
| AstraZeneca Pharmaceuticals LP | 10 | $174 |
| ANI Pharmaceuticals, Inc. | 7 | $167 |
Products named: Bimzelx, RINVOQ, SKYRIZI, BENLYSTA, COSENTYX, TALTZ, ACTHAR, TREMFYA.
Industry payments across CA — which companies pay providers there.
